new schizophrenia drug cobenfy

Cobenfy: The First New Schizophrenia Drug in Decades

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other antipsychotics.

Time on MSN · 5d

FDA Approves the First New Schizophrenia Drug in Decades

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.

ABC on MSN · 6d

FDA approves 1st new drug for schizophrenia in more than 30 years

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years.

scmp.com2d

Experts hail new schizophrenia drug Cobenfy as a game-changer, the ‘first of its kind’

British scientists have hailed the US approval of a new drug for schizophrenia ... has approved the new drug Cobenfy, which is owned by American pharmaceutical firm Bristol Myers Squibb.

Valley News Live2d

FDA approves new drug for schizophrenia, described as a potential ‘game changer’

FARGO, N.D. (Valley News Live) - Changes are coming to the way schizophrenia is treated. The US Food and Drug ...

ScienceAlert2d

First New Schizophrenia Treatment in Decades a Much-Needed Alternative

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Boise State Public Radio5d

A new kind of drug for schizophrenia promises fewer side effects

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results